摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

| 1294006-21-5

中文名称
——
中文别名
——
英文名称
——
英文别名
——
化学式
CAS
1294006-21-5
化学式
C19H31N3O3
mdl
——
分子量
349.5
InChiKey
YFGLJBHRHUNTSP-QZNHQWIBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    480.4±45.0 °C(Predicted)
  • 密度:
    1.157±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.14
  • 重原子数:
    25.0
  • 可旋转键数:
    2.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.79
  • 拓扑面积:
    75.87
  • 氢给体数:
    1.0
  • 氢受体数:
    4.0

反应信息

  • 作为反应物:
    描述:
    在 platinum on activated charcoal 、 氢气三乙酰氧基硼氢化钠三乙胺三氟乙酸 作用下, 以 二氯甲烷溶剂黄146 为溶剂, 20.0 ℃ 、275.8 kPa 条件下, 生成
    参考文献:
    名称:
    Design and synthesis of novel CCR2 antagonists: Investigation of non-aryl/heteroaryl binding motifs
    摘要:
    This report describes the design and synthesis of a series of CCR2 antagonists incorporating novel non-aryl/heteroaryl RHS (right hand side) motifs. Previous SAR in the area has suggested an aryl/heteroaryl substituent as a necessary structural feature for binding to the CCR2 receptor. Herein we describe the SAR with regards to potency (binding to hCCR2), dofetilide activity and metabolic stability (in vitro HLM) for this series. The resulting outcome was the identification of compounds with excellent properties for the investigation of the role of CCR2 in disease. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2011.01.052
  • 作为产物:
    描述:
    (1S,4S)-4-(2,5-二甲基-1H-吡咯-1-基)-1-异丙基-2-环戊烯羧酸羟胺 、 O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate 、 三乙胺 作用下, 以 四氢呋喃N,N-二甲基甲酰胺 为溶剂, 生成
    参考文献:
    名称:
    Design and synthesis of novel CCR2 antagonists: Investigation of non-aryl/heteroaryl binding motifs
    摘要:
    This report describes the design and synthesis of a series of CCR2 antagonists incorporating novel non-aryl/heteroaryl RHS (right hand side) motifs. Previous SAR in the area has suggested an aryl/heteroaryl substituent as a necessary structural feature for binding to the CCR2 receptor. Herein we describe the SAR with regards to potency (binding to hCCR2), dofetilide activity and metabolic stability (in vitro HLM) for this series. The resulting outcome was the identification of compounds with excellent properties for the investigation of the role of CCR2 in disease. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2011.01.052
点击查看最新优质反应信息

文献信息

  • 3-aminocyclopentanecarboxamides as chemokine receptor agonists
    申请人:Hughes Robert O.
    公开号:US08946413B2
    公开(公告)日:2015-02-03
    There is provided a compound of Formula I(a) or I(b): or a pharmaceutically acceptable salt thereof, wherein the various substitutents are defined herein.
    提供一种I(a)或I(b)式的化合物:或其药学上可接受的盐,其中各种取代基在此定义。
查看更多